跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,097 条关于
“biologic DMARDs”
全部
6,097
临床试验
3,876
药物
517
机构
137
资讯
1,567
7个月前
SynAct Pharma Completes Enrollment in Phase 2b Trial of Resomelagon for Newly Diagnosed Rheumatoid Arthritis
去年
Large Real-World Study Finds No Increased Cancer or Cardiovascular Risk with JAK Inhibitors in Rheumatoid Arthritis
去年
FDA Approves First Neuroimmune Modulation Device for Rheumatoid Arthritis Treatment
8个月前
Lynk Pharmaceuticals Reports Positive Phase III Results for Zemprocitinib in Rheumatoid Arthritis
2年前
Digital Study Design Optimizes Patient Engagement and Data Completeness in Rheumatoid Arthritis Research
3个月前
SynAct's Resomelagon Hits Key Endpoints in Phase 2b Rheumatoid Arthritis Trial, Secures US Patent Exclusivity to 2044
上个月
Placental biology breakthrough could make biologic medicines safer during pregnancy
去年
Alfasigma Takes Over Marketing of Jyseleca in Europe Following Acquisition from Galapagos
去年
Expanding Biologic Options Transform Treatment Landscape for Psoriatic Arthritis
去年
ZL-1310 Demonstrates Promising Efficacy in Recurrent Small Cell Lung Cancer
第 1 页,共 157 页
上一页
下一页